1. Home
  2. APAM vs NAMS Comparison

APAM vs NAMS Comparison

Compare APAM & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APAM
  • NAMS
  • Stock Information
  • Founded
  • APAM 1994
  • NAMS 2019
  • Country
  • APAM United States
  • NAMS Netherlands
  • Employees
  • APAM N/A
  • NAMS N/A
  • Industry
  • APAM Investment Managers
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • APAM Finance
  • NAMS Health Care
  • Exchange
  • APAM Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • APAM 2.9B
  • NAMS 2.5B
  • IPO Year
  • APAM 2013
  • NAMS N/A
  • Fundamental
  • Price
  • APAM $46.58
  • NAMS $21.96
  • Analyst Decision
  • APAM Hold
  • NAMS Strong Buy
  • Analyst Count
  • APAM 6
  • NAMS 8
  • Target Price
  • APAM $42.25
  • NAMS $42.88
  • AVG Volume (30 Days)
  • APAM 616.9K
  • NAMS 938.1K
  • Earning Date
  • APAM 07-22-2025
  • NAMS 08-06-2025
  • Dividend Yield
  • APAM 7.58%
  • NAMS N/A
  • EPS Growth
  • APAM 10.09
  • NAMS N/A
  • EPS
  • APAM 3.64
  • NAMS N/A
  • Revenue
  • APAM $1,124,598,000.00
  • NAMS $47,140,000.00
  • Revenue This Year
  • APAM $3.53
  • NAMS N/A
  • Revenue Next Year
  • APAM $5.21
  • NAMS N/A
  • P/E Ratio
  • APAM $12.88
  • NAMS N/A
  • Revenue Growth
  • APAM 11.90
  • NAMS 586.97
  • 52 Week Low
  • APAM $32.75
  • NAMS $14.06
  • 52 Week High
  • APAM $49.54
  • NAMS $27.29
  • Technical
  • Relative Strength Index (RSI)
  • APAM 67.04
  • NAMS 62.67
  • Support Level
  • APAM $45.93
  • NAMS $17.97
  • Resistance Level
  • APAM $48.50
  • NAMS $22.15
  • Average True Range (ATR)
  • APAM 1.03
  • NAMS 0.92
  • MACD
  • APAM 0.23
  • NAMS 0.33
  • Stochastic Oscillator
  • APAM 76.81
  • NAMS 82.59

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: